Previous reports have characterized inferior early repolarization (ER) as a harbinger of increased risk for sudden death. In the present study, the investigators analyzed ER from 12-lead ECGs of 10 864 randomly selected middle-aged subjects and tested the hypothesis that variations in the ST-segment characteristics after the ER waveforms may have prognostic importance. The novel observations from the present community-based study suggest that ER with rapidly ascending ST segment in inferior or lateral leads of a 12-lead ECG, which is frequently observed in young healthy athletes, is a benign variant, similar to that observed in leads V1-V3, at least in middle-aged subjects. Subjects with this ECG pattern should not be profiled as high risk, and would not require specific cardiovascular evaluations or treatment if they are asymptomatic without a family history of sudden cardiac death or serious arrhythmias. In contrast, a specific ER pattern in inferior leads of a standard 12-lead ECG with a horizontal/descending ST segment appears to be associated with an increased risk of arrhythmic death and a high amplitude of J-point elevation increases the risk even further. The pathogenesis, background, and treatment of such subjects with high-amplitude ER and horizontal/ downsloping ST segment warrant further research. See p 2666.
Circumstances and Outcomes of Sudden Unexpected Death in Patients With High-Risk Myocardial Infarction: Implications for Prevention
Sudden unexpected death is a frequent catastrophic complication in patients after myocardial infarction. For patients such as those with reduced ejection fraction immediately after myocardial infarction who are not eligible for implantable cardioverter-defibrillator therapy, strategies for prevention have remained elusive. In this study, we explored the circumstances of sudden death events in patients with high-risk myocardial infarction. We showed that only half of sudden death events occurring at home were witnessed, in part because of a high proportion (Ϸ50%) of events occurring during sleep. We also demonstrated that early after myocardial infarction there was an increased likelihood of sudden death events occurring in hospital (44% within the first 40 days versus 21% for the entire follow-up period). Taken together, these findings help to explain the lack of efficacy of home automatic external defibrillators and suggest that strategies for prevention in this patient population should take into account the circumstances of sudden death events. Finally, we assessed the outcomes of patients who were successfully resuscitated after cardiac arrest, illustrating the benefit of secondary prevention implantable cardioverter-defibrillator therapy (hazard ratio for death 0.36; Pϭ0.04). See p 2674.
Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality: Insights From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38)
Several recent studies have shown that intensified dual antiplatelet therapy can reduce the risk of major cardiovascular events in patients with acute coronary syndromes, but with an increase in bleeding. The balance between benefit (prevention of ischemic events) and risk (significant bleeding) is therefore a key consideration in choosing the intensity of antiplatelet therapy. This analysis of the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38), which compared prasugrel to standard-dose clopidogrel in patients with acute coronary syndromes undergoing a planned percutaneous coronary intervention, showed that the most common types of serious bleeding were gastrointestinal and vascular access site bleeding. Variables most strongly associated with risk of serious bleeding were female sex, use of a glycoprotein IIb/IIIa inhibitor, duration of intervention, age, assignment to prasugrel, ST-elevation myocardial infarction, femoral access for angiography, creatinine clearance, hypercholesterolemia, and hypertension. Serious bleeding was significantly associated with mortality after correction for these factors. Analyses focusing on the time dependency of this relationship showed that this association existed only for the first week after an instrumented or traumatic bleeding event. After a spontaneous serious bleeding event, bleeding was significantly associated with mortality for Ϸ40 days. There did not appear to be a prolonged hazard beyond these time periods. See p 2681. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) usually shows an autosomal dominant inheritance pattern, with incomplete penetrance and variable clinical expression. Classically, index patients present between the second and fourth decades of life with right ventricular tachycardia. However, sudden death can occur at adolescence, whereas mutation carriers may remain without signs and symptoms until old age. Previous genotype-phenotype studies involved mainly overt index patients. Data on mainly asymptomatic relatives were scarce. To gain insight into the full spectrum of the disease, 149 ARVD/C index patients and 302 of their relatives were genotypically and phenotypically characterized. DNA analysis comprised sequencing of the desmosomal genes PKP2, DSC2, DSG2, DSP, and JUP and multiplex ligationdependent probe amplification to identify large deletions in PKP2. Pathogenic mutations were identified in 87 of 149 ARVD/C index patients (58%), mainly truncating PKP2 mutations with multiple mutations in 2% of cases. Performing multiplex ligation-dependent probe amplification also appeared to be important; its 2% mutational yield was comparable to the sequencing of DSG2 or DSC2. Identification of mutations in index patients had major consequences for the concurrent relatives. Of the 57 of 282 initially asymptomatic relatives (20%) who showed any sign of ARVD/C, 84% carried a mutation. These 48 mutation carriers had earlier onset of disease signs and symptoms than noncarriers but also a markedly increased risk of arrhythmias and 6-fold risk of ARVD/C diagnosis. Familial cases were identified in 45% of families screened. Prolonged terminal activation duration seemed to be an early marker of ARVD/C; it was observed more often than negative T waves in V 1 to V 3 , especially in mutation-carrying relatives Ͻ20 years of age. See p 2690.
Arrhythmogenic Right Ventricular
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Familial Evaluation in Arrhythmogenic Right Ventricular Cardiomyopathy: Impact of Genetics and Revised Task Force Criteria
Arrhythmogenic right ventricular cardiomyopathy is a genetically determined autosomal dominant cardiac disorder caused by mutations in desmosomal genes. Clinical presentation is typically with arrhythmia and/or sudden death during the second and third decades. This study confirms this perspective; 51 of 100 probands presented with sudden death, 14 between the ages of 14 and 20 years. The study also examined family members in whom the molecular genetic status was known. Disease expression in relatives was milder, developed later in life, and was associated with a low incidence of arrhythmia/sudden death. Relatives with multiple genetic variants, however, had more severe disease expression with sudden death. It is unclear whether multiple variants explain the early presentation with sudden death seen in Ͼ30% of probands, or whether later-onset disease is progressive with clinical arrhythmia complications developing in later decades. The findings of this study underscore the role of mutation analysis with cascade screening of families to enable appropriate genetic counseling and targeted serial cardiac evaluation. See p 2701.
Differences in Admitting Hospital Characteristics for Black and White Medicare Beneficiaries With Acute Myocardial Infarction
Recent research has identified differential access to high-quality hospital care as an important, perhaps primary, factor associated with racial disparities in the treatment of acute myocardial infarction. However, the reasons why minorities are more often treated at hospitals with relatively lower quality of care are not fully understood. We examined the relationship between patient race, distance, and admissions to hospitals with particular characteristics (eg, provision of revascularization services, quality ranks) available to patients within defined hospital markets. We found that, after accounting for distance from home to available hospitals, black patients were overall less likely to be admitted to the closest hospitals, to hospitals with revascularization programs, and to high-quality hospitals. In secondary analyses limited to black and white patients living in similar ZIP codes, these differences were attenuated and not statistically significant. Our findings suggest that differences in admissions to hospitals with particular characteristics are not driven exclusively by race, but also by characteristics of the environment in which patients live. Such local context factors may include economic factors, community culture (eg, perceived discrimination, high levels of distrust in the healthcare system), and physician referral practices. Practicing physicians need to be aware of and sensitive to such potential local barriers in access to high-quality care. See p 2710.
Relationship Between Supranormal Oxygen Tension and Outcome After Resuscitation From Cardiac Arrest
Historically, the administration of supplemental oxygen has been considered a cornerstone of cardiopulmonary resuscitation for victims of cardiac arrest. However, laboratory experiments and recent clinical data suggest that after a pulse is restored, excessive supplemental oxygen could be harmful. Supranormal oxygen tension can exacerbate oxygen free radical formation and subsequent reperfusion injury. However, it is unclear if the risk of poor outcome is a threshold effect at a specific supranormal oxygen tension, or is a dose-dependent association. The authors studied patients admitted to an intensive care unit after resuscitation from cardiac arrest at 120 US hospitals. After excluding patients with hypoxia, there were 4459 patients in the sample. The authors tested the association between postresuscitation arterial partial pressure of oxygen and in-hospital mortality. The median postresuscitation arterial partial pressure of oxygen was 231 (interquartile range 149 -349) mm Hg. Fifty-four percent of the patients died. Over ascending ranges of oxygen tension, the authors found significant linear trends of increasing in-hospital mortality and decreasing survival as functionally independent. On multivariable analysis adjusted for patient-oriented covariates and potential hospital effects, a 100 mm Hg increase in postresuscitation arterial partial pressure of oxygen was associated with a 24% increase in relative risk of death. The authors observed no evidence supporting a single threshold for harm from supranormal oxygen tension. In this large sample of postresuscitation patients, the authors found that the association between supranormal oxygen tension and risk of in-hospital death is a linear dose-dependent relationship. These data provide further support that supranormal oxygen tension may be harmful in patients resuscitated from cardiac arrest. See p 2717.
